Found: 71
Select item for more details and to access through your institution.
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy of secretory pituitary adenomas.
- Published in:
- BMC Endocrine Disorders, 2010, v. 10, p. 10, doi. 10.1186/1472-6823-10-10
- By:
- Publication type:
- Article
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency.
- Published in:
- Pituitary, 2023, v. 26, n. 1, p. 57, doi. 10.1007/s11102-022-01283-3
- By:
- Publication type:
- Article
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2).
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 959, doi. 10.1007/s11102-022-01280-6
- By:
- Publication type:
- Article
Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 795, doi. 10.1007/s11102-022-01268-2
- By:
- Publication type:
- Article
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program.
- Published in:
- Pituitary, 2021, v. 24, n. 4, p. 611, doi. 10.1007/s11102-021-01138-3
- By:
- Publication type:
- Article
Correction to: Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
- Published in:
- Pituitary, 2021, v. 24, n. 1, p. 104, doi. 10.1007/s11102-020-01103-6
- By:
- Publication type:
- Article
A Pituitary Society update to acromegaly management guidelines.
- Published in:
- Pituitary, 2021, v. 24, n. 1, p. 1, doi. 10.1007/s11102-020-01091-7
- By:
- Publication type:
- Article
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 6, p. 859, doi. 10.1530/EJE-22-0506
- By:
- Publication type:
- Article
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 4, p. 531, doi. 10.1530/EJE-22-0317
- By:
- Publication type:
- Article
Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 1, p. 27, doi. 10.1530/EJE-21-1167
- By:
- Publication type:
- Article
All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis.
- Published in:
- European Journal of Endocrinology, 2020, v. 182, n. 3, p. 285, doi. 10.1530/EJE-19-0794
- By:
- Publication type:
- Article
Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease.
- Published in:
- European Journal of Endocrinology, 2020, v. 182, n. 2, p. 207, doi. 10.1530/EJE-19-0695
- By:
- Publication type:
- Article
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY.
- Published in:
- European Journal of Endocrinology, 2018, v. 179, n. 6, p. 419, doi. 10.1530/EJE-18-0616
- By:
- Publication type:
- Article
Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant.
- Published in:
- European Journal of Endocrinology, 2018, v. 178, n. 4, p. 321, doi. 10.1530/EJE-17-0996
- By:
- Publication type:
- Article
MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.
- Published in:
- European Journal of Endocrinology, 2017, v. 176, n. 3, p. 283, doi. 10.1530/EJE-16-0748
- By:
- Publication type:
- Article
Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis.
- Published in:
- European Journal of Endocrinology, 2017, v. 176, n. 2, p. 213, doi. 10.1530/EJE-16-0697
- By:
- Publication type:
- Article
Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.
- Published in:
- European Journal of Endocrinology, 2016, v. 174, n. 6, p. C1, doi. 10.1530/eje-16-0111
- By:
- Publication type:
- Article
Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak.
- Published in:
- European Journal of Endocrinology, 2013, v. 168, n. 5, p. 733, doi. 10.1530/EJE-13-0005
- By:
- Publication type:
- Article
A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis.
- Published in:
- European Journal of Endocrinology, 2012, v. 167, n. 3, p. 343, doi. 10.1530/EJE-12-0070
- By:
- Publication type:
- Article
Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.
- Published in:
- European Journal of Endocrinology, 2012, v. 166, n. 4, p. 593, doi. 10.1530/EJE-11-0942
- By:
- Publication type:
- Article
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2020, v. 105, n. 4, p. e1358, doi. 10.1210/clinem/dgaa049
- By:
- Publication type:
- Article
Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Growth Hormone Replacement on BMD in Adult-Onset Growth Hormone Deficiency.
- Published in:
- Journal of Bone & Mineral Research, 2007, v. 22, n. 5, p. 762, doi. 10.1359/JBMR.070205
- By:
- Publication type:
- Article
Potential Cardiac Valve Effects of Dopamine Agonists in Hyperprolactinemia.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 3, p. 1025, doi. 10.1210/jc.2009-2095
- By:
- Publication type:
- Article
Delayed remission after transsphenoidal surgery in patients with Cushing's disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Is Lack of Recombinant Growth Hormone (GH)-Releasing Hormone in the United States a Setback or Time to Consider Glucagon Testing for Adult GH Deficiency?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 8, p. 2702, doi. 10.1210/jc.2009-0299
- By:
- Publication type:
- Article
Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Proton Stereotactic Radiotherapy for Persistent Adrenocorticotropin-Producing Adenomas.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2008, v. 93, n. 2, p. 393, doi. 10.1210/jc.2007-1220
- By:
- Publication type:
- Article
Clinical Implications of Residual Growth Hormone (GH) Response to Provocative Testing in Adults with Severe GH Deficiency.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 7, p. 2604, doi. 10.1210/jc.2007-0153
- By:
- Publication type:
- Article
Efficacy of a Long-Acting Growth Hormone (GH) Preparation in Patients with Adult GH Deficiency.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 12, p. 6431, doi. 10.1210/jc.2005-0928
- By:
- Publication type:
- Article
Diagnostic Errors after Inferior Petrosal Sinus Sampling.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 8, p. 3752, doi. 10.1210/jc.2003-032249
- By:
- Publication type:
- Article
Growth Hormone (GH) Replacement Therapy in Adult- Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 5, p. 2048, doi. 10.1210/jc.2003-030346
- By:
- Publication type:
- Article
Androgens and Bone Density in Women with Hypopituitarism.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 6, p. 2770, doi. 10.1210/jcem.87.6.8557
- By:
- Publication type:
- Article
Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH Deficiency.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 5, p. 2067, doi. 10.1210/jcem.87.5.8509
- By:
- Publication type:
- Article
Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 2, p. 477, doi. 10.1210/jcem.87.2.8216
- By:
- Publication type:
- Article
Effects of Growth Hormone (GH) Administration on Homocyst(e)ine Levels in Men with GH Deficiency: A Randomized Controlled Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 4, p. 1518, doi. 10.1210/jcem.86.4.7387
- By:
- Publication type:
- Article
Withdrawal of Long-Term Physiological Growth Hormone (GH) Administration: Differential Effects on Bone Density and Body Composition in Men with AdultOnset GH Deficiency.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 3, p. 970, doi. 10.1210/jcem.85.3.6474
- By:
- Publication type:
- Article
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 10, p. 3419, doi. 10.1210/jcem.83.10.5222
- By:
- Publication type:
- Article
Effects of Physiological Growth Hormone (GH) Therapy on Cognition and Quality of Life in Patients with AdultOnset GH Deficiency.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 9, p. 3184, doi. 10.1210/jc.83.9.3184
- By:
- Publication type:
- Article
Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 1, p. 84, doi. 10.1210/jc.81.1.84
- By:
- Publication type:
- Article
Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1165681
- By:
- Publication type:
- Article
Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.1040046
- By:
- Publication type:
- Article
Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dopamine Agonists Can Reduce Cystic Prolactinomas.
- Published in:
- 2016
- By:
- Publication type:
- journal article